Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours.
Mark R MiddletonEmma DeanThomas R J EvansGeoffrey I ShapiroJohn PollardBart S HendriksMartin FalkIvan Diaz-PadillaRuth PlummerPublished in: British journal of cancer (2021)
NCT02157792.